220 related articles for article (PubMed ID: 11772392)
1. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction.
Ginés S; Mariño M; Mallol J; Canela EI; Morimoto C; Callebaut C; Hovanessian A; Casadó V; Lluis C; Franco R
Biochem J; 2002 Jan; 361(Pt 2):203-9. PubMed ID: 11772392
[TBL] [Abstract][Full Text] [Related]
2. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
Martín M; Huguet J; Centelles JJ; Franco R
J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
[TBL] [Abstract][Full Text] [Related]
3. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
[TBL] [Abstract][Full Text] [Related]
4. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
[TBL] [Abstract][Full Text] [Related]
5. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
[TBL] [Abstract][Full Text] [Related]
6. Regulation of adenosine receptor engagement by ecto-adenosine deaminase.
Hashikawa T; Hooker SW; Maj JG; Knott-Craig CJ; Takedachi M; Murakami S; Thompson LF
FASEB J; 2004 Jan; 18(1):131-3. PubMed ID: 14630704
[TBL] [Abstract][Full Text] [Related]
7. Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.
Gonzalez-Gronow M; Hershfield MS; Arredondo-Vega FX; Pizzo SV
J Biol Chem; 2004 May; 279(20):20993-8. PubMed ID: 15016824
[TBL] [Abstract][Full Text] [Related]
8. Direct association of adenosine deaminase with a T cell activation antigen, CD26.
Kameoka J; Tanaka T; Nojima Y; Schlossman SF; Morimoto C
Science; 1993 Jul; 261(5120):466-9. PubMed ID: 8101391
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26.
Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
Adv Exp Med Biol; 1997; 421():185-92. PubMed ID: 9330696
[TBL] [Abstract][Full Text] [Related]
10. Binding of adenosine deaminase to the lymphocyte surface via CD26.
De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
[TBL] [Abstract][Full Text] [Related]
12. Comodulation of CXCR4 and CD26 in human lymphocytes.
Herrera C; Morimoto C; Blanco J; Mallol J; Arenzana F; Lluis C; Franco R
J Biol Chem; 2001 Jun; 276(22):19532-9. PubMed ID: 11278278
[TBL] [Abstract][Full Text] [Related]
13. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.
Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C
J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406
[TBL] [Abstract][Full Text] [Related]
14. The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression.
Blanco J; Valenzuela A; Herrera C; Lluís C; Hovanessian AG; Franco R
FEBS Lett; 2000 Jul; 477(1-2):123-8. PubMed ID: 10899322
[TBL] [Abstract][Full Text] [Related]
15. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
16. Distribution and expression of A1 adenosine receptors, adenosine deaminase and adenosine deaminase-binding protein (CD26) in goldfish brain.
Beraudi A; Traversa U; Villani L; Sekino Y; Nagy JI; Poli A
Neurochem Int; 2003 May; 42(6):455-64. PubMed ID: 12547644
[TBL] [Abstract][Full Text] [Related]
17. The structure and function of CD26 in the T-cell immune response.
Morimoto C; Schlossman SF
Immunol Rev; 1998 Feb; 161():55-70. PubMed ID: 9553764
[TBL] [Abstract][Full Text] [Related]
18. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
Hühn J; Olek S; Fleischer B; von Bonin A
Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
[TBL] [Abstract][Full Text] [Related]
19. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.
Richard E; Alam SM; Arredondo-Vega FX; Patel DD; Hershfield MS
J Biol Chem; 2002 May; 277(22):19720-6. PubMed ID: 11901152
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells.
Herrera C; Casadó V; Ciruela F; Schofield P; Mallol J; Lluis C; Franco R
Mol Pharmacol; 2001 Jan; 59(1):127-34. PubMed ID: 11125033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
